Chapter 3 Animal Model Market Technology Background
- Methods of Animal Model and 3D Cell Culture Modification
- Physical and Chemical Mutations
- Targeted Mutations
- Other Technologies
- Laboratory Animal Models
- Market Definition
- Animal Model Lines
- Common Species of Laboratory Animals
Chapter 4 Impact of Covid-19 on the Global Market for Organoids
- Overview
- Impact of Covid-19 on Organoids
- Conclusion
Chapter 5 Market Dynamics
- Market Drivers
- Increasing Emphasis on Developing Alternative Approaches to Animal Testing
- Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth
- Increasing Adoption of the Organoid Technology for Wide Range of Applications
- Market Restraints
- Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
- Concerns Associated With the Integration of Organoids into Current Workflows
- Market Opportunities
- Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine
Chapter 6 3D Cell Technology Background
- 3D Cell Cultures
- Spheroids
- 2D Cultures Vs. 2.5D Cultures Vs. 3D Cultures
- Scaffold-Based and Scaffold-Free 3D Cell Cultures
- Scaffold-Free 3D Cell Cultures
- Scaffold-Based 3D Cell Cultures
- Tissue Engineering and Bioprinting
- 3D Bioprinting Technology
- Types of Bioprinting Methods
- Microfluidic Organ-On-Chip Platforms
- Types of Organ-On-Chip Devices
Chapter 7 Market Breakdown by Organ Type
- Global Market for Organoids, by Organ Type
- Intestine
- Market Size and Forecast
- Liver
- Market Size and Forecast
- Stomach
- Market Size and Forecast
- Pancreas
- Market Size and Forecast
- Lung (Pulmonary)
- Market Size and Forecast
- Kidney
- Market Size and Forecast
- Others
- Cardiac Organoids
- Cancer Organoids
- Market Size and Forecast
Chapter 8 Market Breakdown by Application
- Global Market for Organoids, by Application
- Developmental Biology
- Market Size and Forecast
- Drug Discovery and Personalized Medicine
- Market Size and Forecast
- Regenerative Medicine
- Market Size and Forecast
- Pathology of Infectious Disease
- Market Size and Forecast
- Drug Toxicity and Efficacy Testing
- Market Size and Forecast
Chapter 9 Market Breakdown by Region
- Global Market for Organoids, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia-Pacific
- Rest of the World
- Market Size and Forecast
Chapter 11 Analysis of Market Opportunities
- Market Opportunities: Animal Models
- Market Opportunities: 3D Cell Culture Segment
- Organs-On-Chip
- Organoids
- Bioprinting
- Advantages and Disadvantages of 3D Cell Cultures and Animal Models
- Animal Models
- 3D Cell Cultures in General
- Organoids
- Organs-On-Chip
Chapter 13 Profiles of Companies and Important Institutions
- Animal Model Companies
- Alpha Genesis Inc.
- Charles River Laboratories International Inc.
- Envigo
- Genoway S.A.
- Labcorp Drug Development (Covance Inc.)
- The Jackson Laboratory
- Janvier Labs
- Oak Hill Genetics
- Primgen
- Taconic Biosciences
- Transgenic Inc.
- Transposagen Biopharmaceuticals Inc.
- Bioprinting and Regenerative Medicine Companies
- Allevi
- Aspect Biosystems Ltd.
- Bioink Solutions Inc.
- Cellink Inc.
- Collplant Holdings Ltd.
- East River Biosolutions/Xylyx Bio
- Epibone
- Mattek Corp.
- Nano 3D Biosciences Inc.
- Organovo Holdings Inc.
- Pepgel LLC
- Regenhu
- Tevido Biodevices Inc.
- Tissuse GmbH
- Organ-On-Chip Companies
- Axosim
- Emulate Inc.
- Kirkstall Ltd.
- Micronit Microtechnologies
- Mimetas
- Tara Biosystems Inc.
- Organoid Companies
- 3Dnamics Inc.
- Cellesce
- Cincinnati Children's Hospital Medical Center
- Crown Bioscience
- Corning Inc.
- Definigen
- Hubrecht Organoid Technology (Hub)
- Merck Kgaa
- R&D Systems Inc.
- Stemcell Technologies Inc.
- Thermo Fisher Scientific
- Trevigen Inc. (Bio-Techne)
- Other 3D Cell Culture Companies
- 3D Biotek LLC
- Advanced Biomatrix Inc.
- Horizon Discovery Ltd.
- Insphero Inc.
- Promocell GmbH
- Reprocell Inc.
- Synthecon Inc.
List of Tables
Summary Table: Global Market for Organoids, by Organ Type, Through 2027
Table A: Comparison of Changes in the Segmentation of the Old and New Version of the Report
Table 1: Global Market for Organoids, by Organ Type, Through 2027
Table 2: Global Market for Intestine Organoids, by Region, Through 2027
Table 3: Global Market for Liver Organoids, by Region, Through 2027
Table 4: Global Market for Stomach Organoids, by Region, Through 2027
Table 5: Global Market for Pancreatic Organoids, by Region, Through 2027
Table 6: Global Market for Lung Organoids, by Region, Through 2027
Table 7: Global Market for Kidney Organoids, by Region, Through 2027
Table 8: Global Market for Other Organoids Segment, by Region, Through 2027
Table 9: Global Market for Organoids, by Application, Through 2027
Table 10: Global Market for Organoids in Developmental Biology, by Region, Through 2027
Table 11: Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027
Table 12: Global Market for Organoids in Regenerative Medicine, by Region, Through 2027
Table 13: Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027
Table 14: Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027
Table 15: Global Market for Organoids, by Region, Through 2027
Table 16: North American Market for Organoids, by Organ Type, Through 2027
Table 17: North American Market for Organoids, by Country, Through 2027
Table 18: European Market for Organoids, by Organ Type, Through 2027
Table 19: European Market for Organoids, by Country, Through 2027
Table 20: Asia-Pacific Market for Organoids, by Organ Type, Through 2027
Table 21: Asia-Pacific Market for Organoids, by Country, Through 2027
Table 22: Rest of the World Market for Organoids, by Organ Type, Through 2027
Table 23: Review of Selected Patents and Patent Applications on Organoids, 2008-2021
Table 24: Global Number of Transplanted Organs, by Country, 2017
Table 25: Global Organoids Vendors, by Ranking, 2021
Table 26: Alpha Genesis Inc.: Recent Developments, 2017-2020
Table 27: Charles River Laboratories International Inc.: Recent Developments, 2020-2022
Table 28: Envigo: Types of Laboratory Animals
Table 29: Envigo: Recent Developments, 2021-2022
Table 30: GenOway: Recent Developments, 2018-2022
Table 31: LabCorp Drug Development: Recent Developments, 2022
Table 32: The Jackson Laboratory: Recent Developments, 2021
Table 33: Janvier Labs: Segments
Table 34: Taconic Biosciences: Segments
Table 35: Transgenic Inc.: Segments
Table 36: Transgenic Inc.: Company Financials, 2014-2018
Table 37: Transposagen Biopharmaceuticals Inc.: Segments
Table 38: Organovo: Expenses on R&D, 2016-2020
Table 39: Cellesce.: Recent Developments, 2018-2022
Table 40: Cincinnati Children's Hospital Medical Center: Recent Developments, 2021
Table 41: Crown Bioscience: Recent Developments, 2021-2022
Table 42: Corning Inc.: Recent Developments, 2018-2021
Table 43: DefiniGEN: Recent Developments, 2020-2021
Table 44: Hubrecht Organoid Technology (HUB): Recent Developments, 2017-2021
Table 45: Merck KGaA: Products Offered
Table 46: Merck KGaA: Recent Developments, 2020-2021
Table 47: STEMCELL Technologies Inc.: Recent Developments, 2018-2022
Table 48: Thermo Fisher Scientific: Products Offered
Table 49: Thermo Fisher Scientific: Recent Developments
Table 50: 3D Biotek LLC: Segments
Table 51: In Sphero Inc.: Segments
Table 52: Reprocell Inc.: Acquisitions
List of Figures
Summary Figure: Global Market Share for Organoids, by Organ Type, 2021
Figure 1: Timeline for Possible Availability of 3D-Printed Organs and Tissues for Humans, 2018-2043
Figure 2: Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
Figure 3: Global Market Share for Organoids, by Organ Type, 2021
Figure 4: Global Market for Intestine Organoids, 2020-2027
Figure 5: Global Market for Intestine Organoids, by Region, 2020-2027
Figure 6: Global Market for Liver Organoids, 2020-2027
Figure 7: Global Market for Liver Organoids, by Region, 2020-2027
Figure 8: Global Market for Stomach Organoids, 2020-2027
Figure 9: Global Market for Stomach Organoids, by Region, 2020-2027
Figure 10: Global Market for Pancreatic Organoids, 2020-2027
Figure 11: Global Market for Pancreatic Organoids, by Region, 2020-2027
Figure 12: Global Market for Lung Organoids, 2020-2027
Figure 13: Global Market for Lung Organoids, by Region, 2020-2027
Figure 14: Global Market for Kidney Organoids, 2020-2027
Figure 15: Global Market for Kidney Organoids, by Region, 2020-2027
Figure 16: Global Market for Other Organoids Segment, 2020-2027
Figure 17: Global Market for Other Organoids Segment, by Region, 2020-2027
Figure 18: Global Market Share for Organoids, by Application, 2021
Figure 19: Global Market for Organoids in Developmental Biology, 2020-2027
Figure 20: Global Market for Organoids in Developmental Biology, by Region, 2020-2027
Figure 21: Global Market for Organoids in Drug Discovery and Personalized Medicine, 2020-2027
Figure 22: Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, 2020-2027
Figure 23: Global Market for Organoids in Regenerative Medicine, 2020-2027
Figure 24: Global Market for Organoids in Regenerative Medicine, by Region, 2020-2027
Figure 25: Global Market for Organoids in Pathology of Infectious Disease, 2020-2027
Figure 26: Global Market for Organoids in Pathology of Infectious Disease, by Region, 2020-2027
Figure 27: Global Market for Organoids in Drug Toxicity and Efficacy Testing, 2020-2027
Figure 28: Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, 2020-2027
Figure 29: Global Market for Organoids, by Region, 2020-2027
Figure 30: Global Market Share for Organoids, by Region, 2021
Figure 31: North American Market Share for Organoids, by Organ Type, 2021
Figure 32: North American Market Share for Organoids, by Country, 2021
Figure 33: U.S. Market for Organoids, 2020-2027
Figure 34: Canadian Market for Organoids, 2020-2027
Figure 35: European Market Share for Organoids, by Organ Type, 2021
Figure 36: European Market Share for Organoids, by Country, 2021
Figure 37: German Market for Organoids, 2020-2027
Figure 38: French Market for Organoids, 2020-2027
Figure 39: U.K. Market for Organoids, 2020-2027
Figure 40: Italian Market for Organoids, 2020-2027
Figure 41: Spanish Market for Organoids, 2020-2027
Figure 42: Rest of the European Market for Organoids, 2020-2027
Figure 43: Asia-Pacific Market Share for Organoids, by Organ Type, 2021
Figure 44: Asia-Pacific Market Share for Organoids, by Country, 2021
Figure 45: Chinese Market for Organoids, 2020-2027
Figure 46: Japanese Market for Organoids, 2020-2027
Figure 47: Australian Market for Organoids, 2020-2027
Figure 48: Indian Market for Organoids, 2020-2027
Figure 49: Rest of Asia-Pacific Market for Organoids, 2020-2027
Figure 50: Rest of the World Market Share for Organoids, by Organ Type, 2021
Figure 51: Global Number of Transplanted Organs, by Country, 2017
Figure 52: Charles River Laboratories International Inc.: Net Revenue, 2017-2021
Figure 53: Charles River Laboratories International Inc.: Revenue Share, by Business Segment, 2021
Figure 54: Charles River Laboratories International Inc.: Revenue Share, by Region, 2021
Figure 55: GenOway: Net Revenue, 2019-2021
Figure 56: LabCorp Drug Development: Net Revenue, 2017-2021
Figure 57: LabCorp Drug Development: Revenue Share, by Business Segment, 2021
Figure 58: LabCorp Drug Development: Revenue Share, by Region, 2021
Figure 59: The Jackson Laboratory: Net Revenue, 2018-2020
Figure 60: The Jackson Laboratory: Revenue Share, by Business Segment, 2020
Figure 61: Corning Inc.: Net Revenue, 2019-2021
Figure 62: Corning Inc.: Revenue Share, by Business Segment, 2020
Figure 63: Corning Inc.: Revenue Share, by Region, 2020
Figure 64: Merck KGaA: Net Revenue, 2017-2021
Figure 65: Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 66: Merck KGaA: Revenue Share, by Region, 2020
Figure 67: Thermo Fisher Scientific: Net Revenue, 2017-2021
Figure 68: Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
Figure 69: Thermo Fisher Scientific: Revenue Share, by Region, 2020
